Sanaka, Sirish <br/><br/>
A Downside to Hepatitis C Virus Cure? Vigilance Is Needed Regarding Hepatitis B Virus Reactivation, Organ Rejection, or Hepatocellular Carcinoma Progression.  [electronic resource] 

 -  The Journal of infectious diseases  03 2018 
 - 857-860 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1537-6613 
<br/><br/><label>Standard No.: </label>10.1093/infdis/jix659  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--therapeutic use<br/>Carcinoma, Hepatocellular--etiology<br/>Graft Rejection--etiology<br/>Hepatitis B virus--physiology<br/>Hepatitis C--drug therapy<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Liver Neoplasms--etiology<br/>Recurrence<br/>Virus Activation--drug effects<br/>Virus Latency--drug effects